Recent industry reports have highlighted past and projected rapid expansion in the DNA diagnostics and genomics markets, driven by liquid biopsies, direct-to-consumer testing, and personalized ...

It’s been nearly 15 years since San Diego’s Illumina gained supremacy in DNA sequencing — with just a few rivals competing to deliver the equipment and chemistry to map the genome. But that’s started ...

San Diego’s Illumina is getting closer to sequencing full human genomes at a cost that’s considered the sweet spot for driving wider adoption of personalized medicine based on a patient’s DNA. At its ...

Illumina is welcoming a new addition to its DNA sequencing lineup, with a pair of accessible benchtop instruments that incorporate the tech and chemistry used by its largest, top-of-the-line machines.

Illumina DNA sequencing machines are vulnerable to exploitation. Both the Cybersecurity and Infrastructure Security Agency (CISA) and the Food and Drug Administration (FDA) have published advisories ...

Illumina has refreshed its commitment to chase higher profit margins, with a plan to cut at least $100 million from its annual expenses and slim down operations, all set to take effect later this year ...

Illumina CEO Francis deSouza unveils the NovaSeq X Series sequencing platforms. San Diego-based genomics pioneer Illumina on Thursday introduced a new machine that will sequence a human genome in half ...

SAN FRANCISCO—Illumina said Monday it will join with Nashville Biosciences and Amgen’s deCODE Genetics subsidiary on a collaboration to whole-genome sequence the largest-ever dataset of genomes from ...

Healthcare providers and lab workers using Illumina genetic sequencing instruments are advised to immediately patch the device software against a new vulnerability that the Food and Drug ...

The Food and Drug Administration warned health care providers Thursday that a security vulnerability in DNA sequencers made by Illumina could allow unauthorized users to access or alter potentially ...